Anti-CD20-Interferon Alpha Fusion Protein is a promising therapy for NHL patients resistant to standard therapy
Advances in targeted therapies, immunotherapies and epigenetics among highlights
LLS Helps Launch Contest to Honor NBA Legend Kareem Abdul-Jabbar and Raise Awareness of Blood Cancer
Donor & Community Relations Coordinator
Chris.Williams@LLS.org or call 804-673-5690.
Members of the media should direct inquiries regarding The Leukemia & Lymphoma Society (LLS) Virginia Chapter to: